Optimizing serum 25(OH)D levels to mitigate the risk of age-related ocular diseases: insights from a large-scale prospective cohort study.

Zhiqian Huang, Shuyu Liu, Chao Chen, Keke Zhang, Yu Du, Xiangjia Zhu

Eye Institute, Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.Eye Institute, Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. · pubmed

Paper

Abstract

Investigations into the association between serum 25-hydroxyvitamin D (25(OH)D) levels and the risk of age-related ocular diseases have yielded inconsistent results. Thus, we aimed to provide robust longitudinal evidence, identify optimal serum thresholds, and explore the underlying mechanisms.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that optimizing serum 25(OH)D levels can mitigate the risk of age-related ocular diseases. This research is relevant as it explores potential interventions that could address underlying factors contributing to age-related diseases, aligning with longevity research goals.

Author of this paper? Send a correction.